Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Urinary Incontinence 4Prostatic Neoplasms 4Rectal Neoplasms 2Neoplasms 2Sexual Dysfunction, Physiological 1Prostatic Hyperplasia 1Pancreatic Neoplasms 1Motor Activity 1Low Anterior Resection Syndrome 1Intestinal Diseases 1Hemiplegia 1Fecal Incontinence 1Colonic Neoplasms 1

Interventions

alvimopan 5Irinotecan 4Oxaliplatin 3Capecitabine 3Bevacizumab 3Leucovorin 2Fluorouracil 2Cyclophosphamide 2Cetuximab 2Aspirin 2repotrectinib 1pralsetinib 1pembrolizumab 1napabucasin 1guadecitabine 1encorafenib 1alectinib 1Ursodeoxycholic Acid 1Surveys and Questionnaires 1Pemetrexed 1Oviposition 1Ocoxin 1Levoleucovorin 1KRN-330 1Folfox protocol 1Exercise 1Drug Therapy 1Drainage 1Chemoradiotherapy 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Intestinal Diseases × Biofeedback, Psychology × Clear all
NCT07253298 2026-05-11

BFT in LARS

National Taiwan University Hospital

Phase NA Enrolling by invitation
66 enrolled
Gastrointestinal

Low Anterior Resection Syndrome, Intestinal Diseases, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡